AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $682,000 | -98.8% | 19,800 | -99.4% | 0.04% | -98.9% |
Q2 2020 | $55,447,000 | +16.7% | 3,318,212 | +0.7% | 3.33% | -16.3% |
Q1 2020 | $47,524,000 | -58.0% | 3,295,712 | -2.5% | 3.98% | -36.1% |
Q4 2019 | $113,143,000 | +55.6% | 3,380,441 | -2.6% | 6.23% | +28.6% |
Q3 2019 | $72,698,000 | -8.8% | 3,471,740 | -9.3% | 4.84% | +25.0% |
Q2 2019 | $79,711,000 | -4.9% | 3,828,564 | +2.1% | 3.88% | +10.8% |
Q1 2019 | $83,789,000 | +152.4% | 3,748,939 | +170.2% | 3.50% | +97.8% |
Q4 2018 | $33,191,000 | -11.9% | 1,387,589 | +0.4% | 1.77% | +15.9% |
Q3 2018 | $37,694,000 | +1.5% | 1,381,759 | 0.0% | 1.52% | +2.6% |
Q2 2018 | $37,155,000 | -13.9% | 1,381,759 | +1.9% | 1.48% | -19.6% |
Q1 2018 | $43,178,000 | -0.4% | 1,356,514 | +18.3% | 1.85% | -1.1% |
Q4 2017 | $43,358,000 | +35.2% | 1,146,419 | -11.4% | 1.87% | +38.2% |
Q3 2017 | $32,072,000 | +20.9% | 1,293,764 | +0.3% | 1.35% | +9.1% |
Q2 2017 | $26,517,000 | +4.0% | 1,289,719 | +9.9% | 1.24% | +2.7% |
Q1 2017 | $25,500,000 | +228.4% | 1,173,498 | +209.0% | 1.20% | +172.0% |
Q4 2016 | $7,765,000 | +36.3% | 379,727 | 0.0% | 0.44% | +33.8% |
Q3 2016 | $5,696,000 | +61.7% | 379,727 | +16.6% | 0.33% | +24.4% |
Q2 2016 | $3,523,000 | -20.2% | 325,599 | 0.0% | 0.27% | -22.4% |
Q1 2016 | $4,415,000 | -26.5% | 325,599 | 0.0% | 0.34% | +2.7% |
Q4 2015 | $6,007,000 | -27.1% | 325,599 | 0.0% | 0.33% | -15.7% |
Q3 2015 | $8,244,000 | – | 325,599 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|